Document is current
Any future updates will be listed below
-
Authors
Zulkiewicz, Brittany A
Chen, Jarvis T.
Hanby, Elaine P.
Ramanadhan, Shoba
Obedin-Maliver, Juno
Lunn, Mitchell R.
Scout, N. F. N.
Gordon, Bob
Applegate, Julia
Machado, Ana
Viswanath, Kasisomayajula
Potter, Jennifer
Liu, Sixiao
Tan, Andy S. L.
-
Funding
Funding for this research was provided by:
National Cancer Institute (R01CA237670, R01CA237670, R01CA237670, R01CA237670, R01CA237670, R01CA237670, R01CA237670, R01CA237670, R01CA237670, R01CA237670, R01CA237670, R01CA237670, R01CA237670, R01CA237670)
- License Information
-
More Information
Article History
Received: 6 March 2024
Accepted: 29 October 2024
First Online: 15 November 2024
Declarations
:
: MRL has received consulting fees from Hims, Inc. (2019-present), Folx Health, Inc. (2019-2021), and Otsuka Pharmaceutical Development and Commercialization, Inc. (2023). JOM has consulted for Sage Therapeutics (2017), Ibis Reproductive Health (2017-2018, 2020-present), Hims, Incorporated (2019-present), and Folx, Incorporated (2019-present). None of these engagements influenced or are pertinent to the work described in this manuscript. All other authors do not have any competing interest to declare.
